Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakobdisease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177–188.
Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakobdisease in the UK. Lancet 1996; 347: 921–925.
Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 1994; 35: 385–395.
DeArmond SJ, Bouzamondo E. Fundamentals of prion biology and diseases. Toxicology 2002; 181-182: 9–16.
Pan KM, Baldwin M, Nguyen J, et al. Conversion of ahelices into b-sheets features in the formation of the scrapie prion protein. Proc Natl Acad Sci USA 1993; 90: 10962–10966.
Prusiner SB, Scott M, Foster D, et al. Transgenetic studies implicate interaction between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63: 673–686.
Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448–450.
Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 1997; 389: 498–501.
Wells GAH, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987; 121: 419–420.
Taylor DM. Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Clin Microbiol Infect 2002; 8: 332–339.
Wilesmith JW, Wells GAJ, Cranwell MP, Ryan JBM. Bovine spongiform encephalopathy: Epidemiological studies. Vet Rec 1988; 123: 638–644.
Almond JW, Brown P, Gore SM, et al. Creutzfeldt-Jakobdisease and bovine spongiform encephalopathy: Any connection? Br Med J 1995; 311: 1415–1421.
Spencer MD, Knight RSG, Will RG. First hundred cases of variant Creutzfeldt-Jakobdisease retrospective case note review of early psychiatric and neurological features. Br Med J 2002; 324: 1479–1482.
Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG. MRI of Creutzfeldt-Jakobdisease: Imaging features and recommended MRI protocol. Clin Radiol 2001; 9: 726–739.
Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakobdisease. Ann Neurol 2000; 47: 575–582.
Ironside JW. Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Suppl 2000; 16: 143–151.
Masullo C, Macchi G, Xi YG, Pocchiari M. Failure to ameliorate Creutzfeldt-Jakobdisease with amphotericin B therapy. J Infect Dis 1992; 165: 784–785.
Ladogana A, Casaccia P, Ingrosso L, et al. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol 1992; 73: 661–665.
Korth C, May BC, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 2001; 98: 9836–9841.
Collins J, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL. Quinacrine does not prolong survival in a murine Creutzfeldt-Jakobdisease model. Ann Neurol 2002; 52: 503–506.
Iversen L. Amyloid diseases: Small drugs lead the attack. Nature 2002; 417: 231–233.
White AR, Enever P, Tayebi M, et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 2003; 422: 80–83.
Hill AF, Butterworth RJ, Joiner, et al. Investigation of variant Creutzfeldt-Jakobdisease and other human prion diseases with tonsil biopsy samples. Lancet 1999; 353: 183–189.
Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356: 999–1000.
Andrews NJ, Farrington CP, Cousens SN, et al. Incidence of variant Creutzfeldt-Jakobdisease in the UK. Lancet 2000; 356: 481–482.
Andrews NJ, Farrington CP, Ward HJT, et al. Deaths from variant Creutzfeldt-Jakobdisease in the UK. Lancet 2003; 361: 751–752.
Valleron AJ, Boelle PY, Will R, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726–1728.
d'Aignaux JN, Cousens SN, Smith PG. Predictability of the UK variant Creutzfeldt-Jakobdisease epidemic. Science 2001; 294: 1729–1731.
Ferguson NM, Ghani AC, Donnelly CA, Hagenaars TJ, Anderson RM. Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 2002; 415: 420–424.
Jackson GS, Beck JA, Navarrete C, et al. HLA_DQ7 antigen and resistance to vCJD. Nature 2001; 414: 269–270.
Pepys MB, Bybee A, Booth DR, et al. MHC typing in variant Creutzfeldt-Jakobdisease. Lancet 2003; 361: 487–489.
Glatzel M, Rogivue C, Ghani A, et al. Incidence of Creutzfeldt-Jakobdisease in Switzerland. Lancet 2002; 360: 139–141.
Asante EA, Linehan JM, Desbruslais M, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 2002; 21: 6358–6366.